Endocrinology

Top Story

Insulin pump therapy efficacy sustained in long-term follow-up

May 5, 2016

In patients with type 2 diabetes uncontrolled with multiple daily injection therapy, continuous subcutaneous insulin infusions were effective for reaching glycemic targets, according to findings in a retrospective analysis.

Yves Reznik, MD, of the department of endocrinology at the University of Caen, Côte de Nacre Regional Hospital Center in France, and colleagues evaluated data from 161 patients (mean age, 58.3 years; 51% women; mean diabetes duration, 15 years; mean HbA1c, 9%) with type 2 diabetes who began pump therapy between 1998 and 2012 to determine the long-term efficacy of continuous subcutaneous insulin infusion. Mean duration of follow-up was 5.1 years, and data were collected at pump initiation and annually until the end of follow-up.

In the Journals

Lifestyle interventions improve depression scores in diabetes

May 5, 2016
Adults with type 2 diabetes saw reduced depression scores after completing a variety of lifestyle interventions, according to a recent meta-analysis.“Among short-…
In the Journals

Combined acupuncture, metformin therapy increases insulin sensitivity in diabetes

May 4, 2016
Adults with type 2 diabetes and overweight or obesity randomly assigned 3 weeks of combined acupuncture and metformin lost weight and improved insulin sensitivity vs…
In the Journals

Patients report long-term quality-of-life improvement after duodenal switch surgery

May 4, 2016
Patients who underwent biliopancreatic diversion with duodenal switch surgery reported high mental and physical component scores 12 years after surgery, according to…
In the Journals

ACP, AAIM call for changes to graduate medical education financing

May 4, 2016
The American College of Physicians and the Alliance for Academic Internal Medicine have issued a policy paper outlining recommendations for aligning graduate medical…
More News Headlines »
CME

Diabetic Eye 2015: New Concepts in Screening, Managing, and Referral

This activity is supported by an educational grant from Allergan, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Video
Meeting News Coverage

VIDEO: Testosterone Trials results announcement met with anticipation

April 7, 2016
More »
Featured
Highlights from ENDO 2016

Highlights from ENDO 2016

CME CNE CPE

The Emerging Biosimilar Therapeutic Landscape: Scientific Foundations and Clinical Implications

This activity is supported by an educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Recent processes have been established to facilitate the production, validation, and utilization of biosimilars…
More »
Current Issues
View the Current Issues
morganatic-roan morganatic-roan